Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Correlation of Genogroup I, Genotype 1 (GI.1) Norovirus Neutralizing Antibody Levels With GI.1 Histo-Blood Group Antigen-Blocking Antibody Levels.

The Journal of infectious diseases - 16 Dec 2024

Atmar Robert L, Ettayebi Khalil, Neill Frederick H, Braun Ralph P, Sherwood James, Ramani Sasirekha, Estes Mary K

Abstract excerpt

BACKGROUND: The in vitro cultivation of human noroviruses allows a comparison of antibody levels measured in neutralization and histo-blood group antigen (HBGA)-blocking assays. METHODS: Serum samples collected during the evaluation of an investigational norovirus vaccine (HIL-214 [formerly TAK-214]) were assayed for neutralizing antibody levels against the vaccine's prototype Norwalk virus/genogroup I, genotype...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Blocking
Share to Antibodies, Neutralizing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Antibodies, Viral

Share to Blood Group Antigens

Share to Caliciviridae Infections

Share to Neutralization Tests

Share to Norovirus

Share to Viral Vaccines

Source

Identifiers

PMID: 38864524
DOI: 10.1093/infdis/jiae311

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Correlation of Genogroup I, Genotype 1 (GI.1) Norovirus Neutralizing Antibody Levels With GI.1 Histo-Blood Group Antigen-Blocking Antibody Levels.PMID 38864524Read ↗

Sustained persistence of blockade antibodies against emerging GII.4 and GII.17 noroviruses revealed by a 5-year community-based serological study.Semantic proximity Read ↗

Norovirus Infection in Young Nicaraguan Children Induces Durable and Genotype-Specific Antibody Immunity.Semantic proximity Read ↗

Serological surveillance of GI norovirus reveals persistence of blockade antibody in a Jidong community-based prospective cohort, 2014-2018.Semantic proximity Read ↗

Serological Correlate of Protection against Norovirus‐Induced GastroenteritisSemantic proximity Read ↗

A Bivalent Human Norovirus Vaccine Induces Homotypic and Heterotypic Neutralizing Antibodies.Semantic proximity Read ↗

High serum levels of norovirus genotype-specific blocking antibodies correlate with protection from infection in children.Semantic proximity Read ↗

Characterization of Antigenic Relatedness between GII.4 and GII.17 Noroviruses by Use of Serum Samples from Norovirus-Infected Patients.Semantic proximity Read ↗

Experimental human infection with Norwalk virus elicits a surrogate neutralizing antibody response with cross-genogroup activity.Semantic proximity Read ↗

Norovirus Seroprevalence among Adults in the United States: Analysis of NHANES Serum Specimens from 1999-2000 and 2003-2004.Semantic proximity Read ↗

Heterotypic humoral and cellular immune responses following Norwalk virus infection.Semantic proximity Read ↗

A broadly protective human antibody for GI genogroup norovirusesSemantic proximity Read ↗

Analysis of Archival Sera From Norovirus-Infected Individuals Demonstrates That Cross-Blocking of Emerging Viruses Is Genotype-Specific.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.